CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 23.50
-1.40 (-5.96%)
Jun 17, 2025, 4:35 PM GMT+1
CRISM Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.28 | 0 | 2.89 | 4.93 | 2.04 | Upgrade
|
| Cash & Short-Term Investments | 1.28 | 0 | 2.89 | 4.93 | 2.04 | Upgrade
|
| Cash Growth | 128100.00% | -99.97% | -41.42% | 141.49% | 580.01% | Upgrade
|
| Accounts Receivable | - | 0.01 | - | - | - | Upgrade
|
| Other Receivables | 0.05 | - | - | 0.08 | 0 | Upgrade
|
| Receivables | 0.05 | 0.01 | - | 0.08 | 0 | Upgrade
|
| Inventory | - | - | - | - | 0.15 | Upgrade
|
| Prepaid Expenses | 0.36 | - | 0.05 | - | 0.11 | Upgrade
|
| Other Current Assets | - | - | 20.91 | 18.05 | - | Upgrade
|
| Total Current Assets | 1.69 | 0.01 | 23.85 | 23.07 | 2.31 | Upgrade
|
| Property, Plant & Equipment | 0.05 | 0.07 | - | - | 0.33 | Upgrade
|
| Long-Term Investments | - | - | - | - | 3.85 | Upgrade
|
| Other Intangible Assets | 0.07 | 0.05 | - | - | 17.24 | Upgrade
|
| Total Assets | 1.82 | 0.13 | 23.85 | 23.07 | 23.73 | Upgrade
|
| Accounts Payable | 0.03 | - | 0.11 | 0.71 | 0.22 | Upgrade
|
| Accrued Expenses | 0.14 | 0.01 | 0.51 | - | 0.44 | Upgrade
|
| Short-Term Debt | - | 0.3 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.09 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.17 | 0.02 | 0.15 | 0.12 | 0 | Upgrade
|
| Total Current Liabilities | 0.34 | 0.42 | 0.76 | 0.83 | 0.67 | Upgrade
|
| Long-Term Debt | - | 0.3 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.1 | Upgrade
|
| Total Liabilities | 0.34 | 0.73 | 0.76 | 0.83 | 0.77 | Upgrade
|
| Common Stock | 66.23 | - | 67.05 | 59.41 | 58.92 | Upgrade
|
| Additional Paid-In Capital | 3.36 | - | 3.55 | 3.16 | 3.13 | Upgrade
|
| Retained Earnings | -1.21 | -0.6 | -33.64 | -27.71 | -26.72 | Upgrade
|
| Comprehensive Income & Other | -66.9 | - | -13.88 | -12.63 | -12.38 | Upgrade
|
| Shareholders' Equity | 1.48 | -0.6 | 23.09 | 22.24 | 22.96 | Upgrade
|
| Total Liabilities & Equity | 1.82 | 0.13 | 23.85 | 23.07 | 23.73 | Upgrade
|
| Total Debt | - | 0.7 | - | - | - | Upgrade
|
| Net Cash (Debt) | 1.28 | -0.7 | 2.89 | 4.93 | 2.04 | Upgrade
|
| Net Cash Growth | - | - | -41.42% | 141.49% | 580.01% | Upgrade
|
| Net Cash Per Share | 0.04 | -43.50 | 0.33 | 0.57 | 0.31 | Upgrade
|
| Filing Date Shares Outstanding | 32.68 | 8.71 | 8.71 | 8.62 | 8.62 | Upgrade
|
| Total Common Shares Outstanding | 32.68 | 8.71 | 8.71 | 8.62 | 8.62 | Upgrade
|
| Working Capital | 1.35 | -0.41 | 23.09 | 22.24 | 1.64 | Upgrade
|
| Book Value Per Share | 0.05 | -0.07 | 2.65 | 2.58 | 2.66 | Upgrade
|
| Tangible Book Value | 1.4 | -0.65 | 23.09 | 22.24 | 5.72 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | -0.07 | 2.65 | 2.58 | 0.66 | Upgrade
|
| Machinery | 0.16 | 0.16 | - | - | 3.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.